This week Jørgen Bjerggaard had an interesting discussing about our study on chemoresection with Jonathan Sackier in the EMG health Podcast.
The episode is called: Benefits of Neoadjuvant use of Mitomycin C for the Management of NMIBC
“This episode, sponsored by medac, is a discussion around non-muscle-invasive bladder cancer (NMIBC). We hear from Professor Jørgen Bjerggaard Jensen, who leads clinical research in bladder cancer at the Department of Urology, Aarhus University Hospital, as he explores the management of NMIBC through the neoadjuvant use of Mitomycin C (MMC).”
Finde the episode here